OS Therapies Incorporated
OSTX
$1.79
$0.084.68%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -95.67% | -51.64% | -17.02% | -29.61% | -4.03% |
| Total Depreciation and Amortization | 0.00% | 11.02% | 15,971.43% | -50.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 52.21% | 71.95% | -16.41% | 143.04% | -- |
| Change in Net Operating Assets | 600.41% | -31.47% | 584.70% | -195.50% | 136.96% |
| Cash from Operations | 20.74% | -99.39% | 31.42% | -44.95% | 29.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -68.66% | -- | -- |
| Cash from Investing | -- | 100.00% | -68.66% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -74.56% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -99.94% | -82.60% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 121.35% | -200.00% | -- | -- | -- |
| Cash from Financing | -43.83% | 52.21% | 135.90% | -82.60% | 17.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.63% | -447.57% | 93.40% | -169.72% | 108.45% |